Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Innovative Food Holdings, Inc. Announces Expected First Quarter 2026 Reporting Timeline
-
Meritage Reports First Quarter 2026 Results; Margins Rising, Outlook Better
-
Brookfield Asset Management Announces Results of Annual Meeting of Shareholders
-
Little Glass House Studio Brings Natural Light Photography Space to the Boston Area as Candid, Lifestyle Imagery Gains Popularity
-
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
-
ISC to Release 2026 First Quarter Financial Results on May 15, 2026
-
Telegram Signal Copier Launches TSC Infinity-A Fully Cloud-Based Telegram Copier for Seamless Trade Automation
-
FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
-
Premier Health Announces Termination of Forbearance Agreements With Principal Lenders and the Continuance of Its Strategic Review Process
-
DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
-
Outbound Sales Pro and Parakeet Promotes Andrew "AJ" Kissh to Head of Marketing
-
Outbound Sales Pro and Parakeet Promotes Andrew "AJ" Kissh to Head of Marketing
-
byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination
-
Sarwa Reaches $1B in Client Assets, a First for a Homegrown UAE Fintech
-
NVIDIA Names Suzanne Nora Johnson to Board of Directors
-
SalesCloser Announces Collaboration with Twilio to Accelerate Customer Deployments
-
Trump Media & Technology Group Reports First Quarter 2026 Results
-
Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)
-
Cornerstone Funds Announce Continuing Monthly Distributions
-
Trump Media & Technology Group Reports First Quarter 2026 Results
-
Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering
-
MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs
-
WeRide Inc. to Hold Annual General Meeting on June 26, 2026
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
High Roller Technologies Schedules Conference Call to Provide a Business Update and Discuss First Quarter 2026 Financial Results
-
ParaZero Announces Receipt of Nasdaq Minimum Bid Price Notification
-
Top Technology Executives Recognized at the 2026 ChicagoCIO ORBIE Awards
-
Koryx Copper Files Technical Report with Updated Mineral Resource Estimate for the Haib Copper Project, Southern Namibia
-
FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
-
Table Trac Announces Quarterly Dividend
-
Rally House Named Official Bookstore Operator for George Mason University, William & Mary, and Rowan University
-
NI Holdings, Inc. Reports Results for First Quarter Ended March 31, 2026
-
Okeanis Eco Tankers Corp. – Invitation to Q1 2026 Results Webcast
-
KULR Technology Group Sets First Quarter 2026 Earnings Call for Thursday, May 14, 2026 at 4:30 p.m. ET
-
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
ICZOOM Group Inc. Announces Change to Extraordinary General Meeting Schedule
-
Motorsport Games to Report First Quarter 2026 Financial Results
-
Lysander Funds Limited Announces Disposition of Units of Canso Credit Income Fund
-
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
-
TOMI Environmental Solutions, Inc. Reports First Quarter 2026 Financial Results and Announces Transformative Letter of Intent to Merge with Carbonium Core, Inc.
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Kandi Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Compliance Deficiency
-
Dynagas LNG Partners LP Announces Cash Distribution for the Quarter Ended March 31, 2026 of $0.050 per Common Unit
-
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs
-
James Cacioppo Files Updated Early Warning Report
-
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
-
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
